First Analysis Upgrades Repligen (RGEN) to Strong Buy
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $149.78 +1.85%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 23
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 23
Join SI Premium – FREE
First Analysis analyst Tracy Marshbanks upgraded Repligen (NASDAQ: RGEN) from Outperform to Strong Buy with a price target of $110.00.
For an analyst ratings summary and ratings history on Repligen click here. For more ratings news on Repligen click here.
Shares of Repligen closed at $79.49 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Upgrades Advanced Energy Industries (AEIS) to Buy
- Deutsche Bank Upgrades Palantir (PLTR) to Buy, 'risk/reward skews favorably'
- Oppenheimer 'Tactically' Upgrades Inspire Medical Systems (INSP) to Outperform 'Despite Noisy Fundamentals'
Create E-mail Alert Related Categories
UpgradesRelated Entities
First AnalysisSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
